Auriga Laboratories has received approval from the Food and Drug Administration to sell a liquid form of one of the most frequently prescribed medications for attention-deficit/hyperactivity disorder. Liquadd is an oral form of the stimulant dextroamphetamine sulfate. The company expects to start selling the product by mid-2008.
Read moreHi everyone. Today I want to talk about a type of skin cancer that is different from an abnormal mole or lesion. Moles or lesions can... Read more »
For many years we've heard about the numerous serious side effects from the osteoporosis medications, namely bisphosphonates that include... Read more »
My school of circumstance was University of Maryland, though considering my diagnosis was smack in the middle of those years, it might as... Read more »
Diabetes is not one disease and different types of diabetes have been identified in the scientific community and discussed in the media. I... Read more »
You may have read some amazing stories of people who claim to have had a complete reversal of their fibromyalgia symptoms from taking... Read more »
There are times when emergency care is necessary for Migraines and severe headaches. In the event that your doctor is not available, it may be... Read more »
Q. How do I go about getting one that fits right? A. This is the perfect opportunity for a shopping trip with a good girlfriend. Bring something to... Read more »
Q. I’m having a mastectomy, and although I’ve heard about reconstruction and implants, I just feel they’re not for me. I think I’d like to... Read more »
Forms and Workbooks to Help Manage Migraines and Headaches Back To School With Migraines or HeadachesWhen your child has a chronic illness,... Read more »
Drugmaker Teva has announced that the U.S. Food and Drug Administration has approved its generic form of the pain patch Duragesic for sale in the... Read more »